Clinical Trial 44150

Long Beach, CA 90806


This trial will be a adaptive, open label, single and/or multiple oral dose, safety, tolerability, food effect trial of CVL-751 in subjects with Parkinson's disease. Part 1 is a placebo-controlled, single dose cohort intended for assessment of safety and tolerability. In case of intolerable AEs, Part 2 would proceed as a multiple dose titration trial to achieve a 15 mg once daily dose while maintaining L-Dopa treatment (Part 2A). 

Qualified Participants Must:

• Be 45-75 years old
• Diagnosed Parkinson's disease
• Be on a stable dose of levodopa

Qualified Participants May Receive:

Compensation for time and travel

Available At:

2600 Redondo ave 4th floor
Long Beach, CA 90806
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.